SenoRx, Inc. Announces Pricing of Initial Public Offering

Published: Mar 29, 2007

ALISO VIEJO, Calif.--(BUSINESS WIRE)--SenoRx, Inc. (NASDAQ:SENO) today announced the initial public offering of 5,500,000 shares of common stock at a price of $8.00 per share. SenoRx has granted the underwriters an option to purchase up to an additional 825,000 shares at the initial public offering price to cover over-allotments, if any. The common stock will trade on the Nasdaq Global Market under the symbol "SENO."

Banc of America Securities LLC and Citigroup Global Markets Inc. are the joint bookrunning managers for the offering. Cowen and Company, LLC and Canaccord Adams Inc. are co-managers.

A registration statement relating to these securities has been filed with, and declared effective by, the Securities and Exchange Commission. This announcement shall not constitute an offer to sell or the solicitation of an offer to buy the common stock of SenoRx, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. Copies of the final prospectus may be obtained from the offices of Banc of America Securities LLC, Capital Markets (Prospectus Fulfillment) by e-mail to or by mail to Banc of America Securities LLC, Capital Markets Operations, 100 West 33rd Street, 3rd Floor, New York, NY 10001, Citigroup Global Markets Inc., 388 Greenwich Street, New York, NY 10013, Cowen and Company, LLC, 1221 Avenue of the Americas, 14th Floor, New York, NY 10020, and Canaccord Adams Inc., 101 Montgomery Street, Suite 2000, San Francisco, CA 94104. Contacts

SenoRx, Inc. Kevin J. Cousins, VP Finance & CFO, 949-362-4800, x109

>>> Discuss This Story

Back to news